Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 6, 2012
Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trialMeyer Michel Samama, Genevieve Contant, Theodore E Spiro, et al.
Thrombosis and Haemostasis|December 22, 2011
Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controlsMeyer Michel Samama, Genevieve Contant, Theodore E Spiro, et al.
Cardiovascular Research|June 17, 2011
A role for coagulation factor Xa in experimental pulmonary arterial hypertensionMartina Delbeck, Katrin F Nickel, Elisabeth Perzborn, et al.
Thrombosis Journal|July 5, 2013
Laboratory assessment of rivaroxaban: a reviewMeyer Michel Samama, Geneviève Contant, Theodore E Spiro, et al.
Journal of Neuroscience Research|December 31, 2016
Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2Ryuta Morihara, Toru Yamashita, Syoichiro Kono, et al.
Journal of Thrombosis and Thrombolysis|July 21, 2011
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro studyAnja Kaeberich, Iris Reindl, Uwe Raaz, et al.
British Journal of Pharmacology|June 28, 2002
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principleJohannes-Peter Stasch, Peter Schmidt, Cristina Alonso-Alija, et al.
Annals of the New York Academy of Sciences|May 25, 2013
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditionsTroy C Sarich, Gary Peters, Scott D Berkowitz, et al.
Pageof 3